Cargando…

Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of Opisthorchis viverrini-Associated Cholangiocarcinoma at Early Cancer Stage

SIMPLE SUMMARY: The mismatch repair (MMR) system prevents DNA mutations, and deficient MMR protein (dMMR) can lead to genetic changes and microsatellite instability (MSI). While dMMR is typically associated with positive outcomes in various cancers, its role in cholangiocarcinoma (CCA) remains uncer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khuntikeo, Natcha, Padthaisong, Sureerat, Loilome, Watcharin, Klanrit, Poramate, Ratchatapusit, Soontaree, Techasen, Anchalee, Jareanrat, Apiwat, Thanasukarn, Vasin, Srisuk, Tharatip, Luvira, Vor, Chindaprasirt, Jarin, Sa-ngiamwibool, Prakasit, Aphivatanasiri, Chaiwat, Intarawichian, Piyapharom, Koonmee, Supinda, Prajumwongs, Piya, Titapun, Attapol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572072/ https://www.ncbi.nlm.nih.gov/pubmed/37835526 http://dx.doi.org/10.3390/cancers15194831

Ejemplares similares

Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand
por: Kunprom, Waritta, et al.
Publicado: (2022)

Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand
por: Aphivatanasiri, Chaiwat, et al.
Publicado: (2022)

Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand
por: Intarawichian, Piyapharom, et al.
Publicado: (2022)

Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression
por: Titapun, Attapol, et al.
Publicado: (2020)

High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection
por: Titapun, Attapol, et al.
Publicado: (2021)

The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand
por: Koonmee, Supinda, et al.
Publicado: (2022)

Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
por: Tomacha, Jittima, et al.
Publicado: (2021)

Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models
por: Thanee, Malinee, et al.
Publicado: (2021)

Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
por: Khophai, Sasikamon, et al.
Publicado: (2018)

In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues
por: Suksawat, Manida, et al.
Publicado: (2019)

A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2020)

Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy
por: Titapun, Attapol, et al.
Publicado: (2023)

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway
por: Daya, Minerva, et al.
Publicado: (2018)

Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2020)

Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth
por: Padthaisong, Sureerat, et al.
Publicado: (2018)

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct
por: Luvira, Vor, et al.
Publicado: (2019)

Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2021)

Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy
por: Thongchot, Suyanee, et al.
Publicado: (2019)

Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma
por: Jongkatkorn, Chaowasaporn, et al.
Publicado: (2023)

Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
por: Kittirat, Yingpinyapat, et al.
Publicado: (2022)

Re-Rising of Total Bilirubin Level after Postoperative Day 3 (The V Pattern) Predicting Liver Failure and Survival of Patients who Underwent Hepatectomy for Cholangiocarcinoma
por: Sawangkajohn, Weerin, et al.
Publicado: (2020)

Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma
por: Leeratanakachorn, Natwutpong, et al.
Publicado: (2021)

In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
por: Dokduang, Hasaya, et al.
Publicado: (2020)

Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand
por: Koonmee, Supinda, et al.
Publicado: (2021)

Frailty Syndrome in Biliary Tract Cancer Patients: Prevalence and Associated Factors
por: Limpawattana, Panita, et al.
Publicado: (2019)

Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients
por: Puetkasichonpasutha, Janpen, et al.
Publicado: (2020)

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
por: Suksawat, Manida, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
por: Wintachai, Preawwalee, et al.
Publicado: (2021)

Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study
por: Kamsa-ard, Supot, et al.
Publicado: (2019)

Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study
por: Kamsa-ard, Supot, et al.
Publicado: (2020)

Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma
por: Deenonpoe, Raksawan, et al.
Publicado: (2022)

Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy
por: Suksawat, Manida, et al.
Publicado: (2018)

Inflammatory Myo-Fibroblastic Tumor of the Gallbladder with Multivisceral Involvement: Successful Treatment with Radical Surgery
por: Losuwarat, Kwanchanok, et al.
Publicado: (2023)

Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells
por: Kulthawatsiri, Thanaporn, et al.
Publicado: (2023)

Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine
por: Kittirat, Yingpinyapat, et al.
Publicado: (2018)

Human Papillomavirus Detection and Abnormal Anal Cytology in HIV-infected Patients Using p16/Ki-67 Dual-Staining
por: Patarapadungkit, Natcha, et al.
Publicado: (2020)

CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression
por: Thanee, Malinee, et al.
Publicado: (2021)

Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles
por: Sitthirak, Sirinya, et al.
Publicado: (2022)

ARID1A alterations and their clinical significance in cholangiocarcinoma
por: Namjan, Achira, et al.
Publicado: (2020)

In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils
por: Khuntikeo, Narong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_om9iqkn1p3s8nghv3k5c67ntb7